Heart Attack Diagnostics Market Size

  • Report ID: 4446
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Heart Attack Diagnostics Market Outlook:

Heart Attack Diagnostics Market size was over USD 13.14 billion in 2025 and is projected to reach USD 27.08 billion by 2035, growing at around 7.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of heart attack diagnostics is evaluated at USD 14.03 billion.

The growth of the market can primarily be ascribed to the rising number of people suffering from heart attacks globally, owing to unhealthy lifestyles, consumption of fatty food items, and illnesses. According to the Centers for Disease Control and Prevention in the United States, about 805,000 people have a heart attack each year. There are 605,000 first-time heart attacks among these. In 200,000 cases, people who have already suffered a heart attack are affected. 

Global heart attack diagnostics market trends such as, the rising disposable income of the population along with rising healthcare expenditure and rapid awareness about health and fitness is expected to boost up the global market in the forecast period. Centers for Medicare & Medicaid Services stated that U.S. health care spending grew 9.7 percent in 2020, reaching USD 4.1 trillion or USD 12,530 per person. Moreover, pre heart attack symptoms should be known by everyone to avoid these unpleasant instances since even a mild heart attack can cause severe medical conditions. Mild heart attack symptoms include tightness & squeezing in the chest, fatigue, heartburn, nausea, dizziness, and others.


Heart Attack Diagnostics Market size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of heart attack diagnostics is evaluated at USD 14.03 billion.

The global heart attack diagnostics market size was worth over USD 13.14 billion in 2025 and is poised to grow at a CAGR of around 7.5%, reaching USD 27.08 billion revenue by 2035.

The North America heart attack diagnostics market will dominate over 39.3% share by 2035, fueled by rising cardiac disease incidence, high healthcare spending, and advanced infrastructure.

Key players in the market include Abbott Laboratories, ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos